US association warns against Alzheimer's tests:
This article was originally published in Clinica
Executive Summary
The Los Angeles Alzheimer's Association has warned against the use of new tests to assist in the diagnosis of the disease. The note of caution coincides with the release of Athena Neurosciences' ADmark Assays (see page 22). "We don't yet know for certain how to interpret these tests, or how useful they will be in diagnosing Alzheimer's disease, " says Peter Braun, executive director of the association. He confirmed the Alzheimer Association's Ronald and Nancy Reagan Research Institute plans to assemble a panel of scientists to advise the medical community and the public on new diagnostic approaches to the disease.